Neuroimaging endpoints in amyotrophic lateral sclerosis

Neuroimaging endpoints in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative, clinically heterogeneous syndrome pathologically overlapping with frontotemporal dementia. To date, therapeutic trials in animal models have not been able to predict treatment response in humans, and the revised Amyotrophic Late...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Menke, R, Agosta, F, Grosskreutz, J, Filippi, M, Turner, M
Natura:	Journal article
Pubblicazione:	Springer Verlag 2016

Documenti analoghi

Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.
di: Turner, M, et al.
Pubblicazione: (2011)

Neuroimaging in amyotrophic lateral sclerosis.
di: Turner, M, et al.
Pubblicazione: (2012)

Basal ganglia alterations in amyotrophic lateral sclerosis
di: Veronica Castelnovo, et al.
Pubblicazione: (2023-04-01)

The tough body at the epicentre of amyotrophic lateral sclerosis
di: Turner, M, et al.
Pubblicazione: (2017)

Structural and functional neuroimaging in amyotrophic lateral sclerosis
di: Ilya S. Bakulin, et al.
Pubblicazione: (2017-08-01)

Assessment of the upper motor neuron in amyotrophic lateral sclerosis
di: Huynh, W, et al.
Pubblicazione: (2016)

One universal common endpoint in mouse models of amyotrophic lateral sclerosis.
di: Jesse A Solomon, et al.
Pubblicazione: (2011-01-01)

Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis
di: Suvi Häkkinen, et al.
Pubblicazione: (2020-11-01)

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
di: B. Kuraszkiewicz, et al.
Pubblicazione: (2020-05-01)

Motor system biomarkers in amyotrophic lateral sclerosis
di: Edmond, EC, et al.
Pubblicazione: (2019)

Developing a Neuroimaging Biomarker for Amyotrophic Lateral Sclerosis: Multi-Center Data Sharing and the Road to a “Global Cohort”
di: Robert Steinbach, et al.
Pubblicazione: (2018-12-01)

A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis
di: Müller, H, et al.
Pubblicazione: (2016)

The reunification of amyotrophic lateral sclerosis
di: Turner, M
Pubblicazione: (2018)

Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study
di: Peter Bede, et al.
Pubblicazione: (2019-01-01)

Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis
di: Swash, M, et al.
Pubblicazione: (2020)

Amyotrophic lateral sclerosis.
di: Kiernan, M, et al.
Pubblicazione: (2011)

NEK1 Variants in a Cohort of Italian Patients With Amyotrophic Lateral Sclerosis
di: Nilo Riva, et al.
Pubblicazione: (2022-04-01)

Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis.
di: Bäumer, D, et al.
Pubblicazione: (2014)

Biomarkers in amyotrophic lateral sclerosis.
di: Turner, M, et al.
Pubblicazione: (2009)

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
di: Menke, R, et al.
Pubblicazione: (2017)

Blood–Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis
di: Tino Prell, et al.
Pubblicazione: (2021-10-01)

Neuroimaging in the Management of Motor Neuron Diseases
di: Filippi, M, et al.
Pubblicazione: (2011)

Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis
di: Keil Carsten, et al.
Pubblicazione: (2012-11-01)

Neuroimaging in primary lateral sclerosis
di: Pioro, EP, et al.
Pubblicazione: (2021)

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
di: Bowser, R, et al.
Pubblicazione: (2011)

Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis
di: Tu, S, et al.
Pubblicazione: (2020)

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
di: R.A.L. Menke, et al.
Pubblicazione: (2018-01-01)

Evolution of white matter damage in amyotrophic lateral sclerosis
di: Gabel, M, et al.
Pubblicazione: (2020)

Circulating MAIT cells in multiple sclerosis and amyotrophic lateral sclerosis
di: Davide De Federicis, et al.
Pubblicazione: (2024-07-01)

Use of vitamins by participants in amyotrophic lateral sclerosis clinical trials.
di: Tino Prell, et al.
Pubblicazione: (2020-01-01)

Defining pre-symptomatic amyotrophic lateral sclerosis
di: Benatar, M, et al.
Pubblicazione: (2019)

Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis
di: Edoardo G. Spinelli, et al.
Pubblicazione: (2020-01-01)

Advances in the application of MRI to amyotrophic lateral sclerosis.
di: Turner, M, et al.
Pubblicazione: (2010)

Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis
di: Dengler Reinhard, et al.
Pubblicazione: (2006-04-01)

Psychiatric disorders prior to amyotrophic lateral sclerosis
di: Turner, M, et al.
Pubblicazione: (2016)

Untangling neuroinflammation in amyotrophic lateral sclerosis
di: Thompson, AG, et al.
Pubblicazione: (2019)

EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.
di: Filippi, M, et al.
Pubblicazione: (2010)

Sweet food preference in amyotrophic lateral sclerosis
di: Turner, M, et al.
Pubblicazione: (2017)

Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis
di: Malcolm Proudfoot, et al.
Pubblicazione: (2019-01-01)

Impaired recognition of disgust in amyotrophic lateral sclerosis is related to basal ganglia involvement
di: Veronica Castelnovo, et al.
Pubblicazione: (2021-01-01)